Glaxo, Isis In Drug Development Deal Of Up To $1.5 Billion
Astellas Extends Tender Offer For OSI To April 23
Eisai Seeks Approval for Breast Cancer Drug Globally
Cash Advance Texas Cash Advance Texas
Glaxo, Isis In Drug Development Deal Of Up To $1.5 Billion
Astellas Extends Tender Offer For OSI To April 23
Eisai Seeks Approval for Breast Cancer Drug Globally
Posted in Industry Stories
Waiting Period Ends For Rigel-AstraZeneca Licensing Agreement Announced Last Month
Update 1- Eli Lilly Says To Launch 15 New Products In China
Stada Sees Chance for Growth In 2010 Earnings, Sales (Update 2)
Regulators Reject a Drug Maker’s Plan To Use Its Alertness Pill To Overcome Jet Lag
Sanofi, Bristol Reap Two Victories on Plavix
Read the rest of this entry »
Posted in Industry Stories
Test Predicts Which Patient Benefit From $6Billion MS Drugs
F.D.A. Says Millions Got Unapproved Heart Pills
Obama to Nominate Berwick for Medicare-Medicaid Post
Healthcare Overhaul Q & A How the New Health Law Could Affect You, and How Soon
For Many, MS drugs Not Helpful, Study Shows
Read the rest of this entry »
Posted in Industry Stories
More Doctors Giving Up Private Practices
Pfizer Loses Lipitor Patent Suits in South Korea, Court Says
CVS Caremark Task Force Probe Includes Connecticut, Illinois
Merkel Breaks Drugmaker Hold on Prices With Cost-Cutting Plan
Focus Less On Price, More On Value, Says Lilly Chief
Read the rest of this entry »
Posted in Industry Stories
G.O.P. Forces New House Vote on Fixes to Health Bill
Democrats Promote Overhaul’s Benefits to Older Americans
Coburn’s Erectile Dysfunction Amendment is Killed
Social Networks a Lifeline for the Chronically Ill
Health Law Surprise Is Page 1,617 Demanding Which Drugs Work
Read the rest of this entry »
Posted in Industry Stories
Deal Provides Vaccines to Poor Nations at Low Cost
Health Care Suits by States ‘Unlikely to Succeed,’ Scholars Say
U.S. Medicare To Pay For “Fillers” in HIV Patients
Breast Cancer Screening Fails to Reduce Deaths in Danish Study
Tanning Tax, Family Insurance to Take Effect in 2010
Read the rest of this entry »
Posted in Industry Stories
Health Vote is Done, But Partisan Debate Rages On
Health Measure’s Opponents Plan Legal Challenges
Republicans Dealt Blow on Health Care by US Senate Official
Merck Suspends Stimuvax Studies on Side Effect
GW Pharmaceuticals Reports Data From Sativex Phase IIB Trial
Read the rest of this entry »
Posted in Industry Stories
In Health Care Reform, Boons for Hospitals and Drug Makers
PhRMA Statement on Health Care Reform
Sanofi’s Multaq Tests Indicate Low Price in France, Tribune Says
Drug Trials Have Excluded Gays
US Senate Panel Commence Drug Pricing Probe
Read the rest of this entry »
Posted in Industry Stories
A Company Races to Keep a Drug Patent
Ratiopharm Gives Teva ‘Last Ticket’ to German Generics Market
Diabetes Drug Supporters Had Financial Tie to Glaxo, Study Says
Pfizer Drops Viagra Infringement Case Against Lilly
AstraZeneca Wins First Seroquel Trial, Signs Alzheimer’s Pact
Read the rest of this entry »
Posted in Industry Stories
Posted in Industry Stories